CollPlant Biotechnologies Ltd.

NasdaqGM:CLGN Stock Report

Market Cap: US$50.0m

CollPlant Biotechnologies Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CLGN?
Owner TypeNumber of SharesOwnership Percentage
Private Companies87,2370.762%
Institutions2,010,16917.5%
Individual Insiders3,547,33631%
General Public5,809,77050.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 49.28% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
17%
Ami Sagyp
1,943,184US$8.5m0%no data
9.64%
George Loewenbaum
1,103,846US$4.8m0%no data
4.3%
Meitav Investment House Ltd
492,619US$2.2m0%0.02%
4.23%
St. Denis J. Villere & Co., LLC
484,867US$2.1m24.4%0.19%
4.09%
Pinnacle Associates, Ltd.
468,109US$2.0m-17.1%0.03%
3.3%
Hugh Evans
377,430US$1.6m0%no data
2.41%
Roumell Asset Management, LLC
276,430US$1.2m0%1.93%
1.04%
Brown Advisory Incorporated
119,465US$521.8k0%no data
0.87%
AMH Equity, Ltd.
99,205US$433.3k31.1%0.49%
0.6%
Lillian Loewenbaum
69,051US$301.6k0%no data
0.49%
The Loewenbaum 1992 Trust
56,030US$244.7k0%no data
0.27%
Waterproof Partnerships Ltd
31,207US$136.3k0%no data
0.27%
Yehiel Tal
31,137US$136.0k0%no data
0.21%
Benjamin Edwards, Inc, Asset Management Arm
23,810US$104.0k-40.1%no data
0.18%
Elizabeth Loewenbaum
20,688US$90.4k0%no data
0.15%
Pathstone Family Office, LLC
17,000US$74.2k0%no data
0.1%
UBS Asset Management AG
11,947US$52.2k67.3%no data
0.053%
Geode Capital Management, LLC
6,018US$26.3k7.31%no data
0.035%
Wells Fargo & Company, Securities and Brokerage Investments
4,000US$17.5k0%no data
0.028%
Parallel Advisors, LLC
3,253US$14.2k-0.03%no data
0.025%
Merrill Lynch & Co. Inc., Banking Investments
2,825US$12.3k-61.3%no data
0.017%
Philippe Bensimon
2,000US$8.7k0%no data
0.0022%
National Bank Investments Inc.
250US$1.1k0%no data
0.0018%
Advisor Group Holdings, Inc., Asset Management Arm
200US$875.50%no data
0.0015%
Osaic Wealth, Inc. , Asset Management Arm
170US$740.40%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 23:41
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CollPlant Biotechnologies Ltd. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jason KolbertD. Boral Capital LLC.
Linda PomeroyEdison Investment Research
Swayampakula RamakanthH.C. Wainwright & Co.